Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04777981
Status:
UNKNOWN
Last Update Posted:
2022-02-22
First Post:
2021-02-25
Brief Title:
CBDRA60 to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC
Sponsor:
Anewsha Therapeutics Inc
Organization:
Anewsha Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-12-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12-28
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-25
First Submit QC Date:
February 28 2021
Study First Post Date:
2021-03-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-18
Last Update Post Date:
2022-02-22
Last Update Post Date Type:
ACTUAL